Global Male Infertility Market Size To Worth USD 5.34 Billion By 2033 | CAGR of 3.49%
April 18, 2024 16:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, April 18, 2024 (GLOBE NEWSWIRE) -- The Global Male Infertility Market Size is to Grow from USD 3.79 Billion in 2023 to USD 5.34 Billion by 2033, at a Compound Annual Growth...
Global Biochips Market Size and Share to Grow by 2030, Accesses DelveInsight | Key Players in the Market - Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, Qiagen, Abbott, Hoffmann La-Roche, Cepheid
April 18, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, April 18, 2024 (GLOBE NEWSWIRE) -- Global Biochips Market Size and Share to Grow by 2030, Accesses DelveInsight | Key Players in the Market - Thermo Fisher Scientific, Agilent...
Global Anti-hypertensive Drug Market Size To Exceed USD 50 Billion By 2033 | CAGR of 7.18%
April 18, 2024 10:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, April 18, 2024 (GLOBE NEWSWIRE) -- The Global Anti-hypertensive Drug Market Size is to Grow from USD 25 Billion in 2023 to USD 50 Billion by 2033, at a Compound Annual...
RSV Vaccine Market To Reach USD 2.2 Billion By 2032 | DataHorizzon Research
April 18, 2024 06:10 ET
|
DataHorizzon Research
Fort Collins, Colorado, April 18, 2024 (GLOBE NEWSWIRE) -- Growing prevalence of RSV in the population drives the need for RSV vaccines. RSV, a prevalent respiratory virus, often leads to severe...
Weight Management Supplement Market Set to Soar at 14.2% CAGR through 2034 Amid Rising Prevalence of Obesity Globally | Future Market Insights, Inc.
April 17, 2024 20:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, April 17, 2024 (GLOBE NEWSWIRE) -- According to Future Market Insights, sales of weight management supplements are estimated to total US$ 5.24 billion in 2024 and further grow at 14.2%...
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
April 17, 2024 16:05 ET
|
89bio, Inc.
SAN FRANCISCO, April 17, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for...
Global Pediatric Drugs And Vaccines Market Size To Exceed USD 265.5 Billion By 2033 | CAGR of 8.04%
April 17, 2024 15:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, April 17, 2024 (GLOBE NEWSWIRE) -- The Global Pediatric Drugs and Vaccines Market Size is to Grow from USD 122.5 Billion in 2023 to USD 265.5 Billion by 2033, at a Compound...
Global Cytotoxic Drugs Market Size To Exceed USD 27.62 Billion By 2033 | CAGR Of 5.39%
April 17, 2024 13:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 17, 2024 (GLOBE NEWSWIRE) -- The Global Cytotoxic Drugs Market Size is to Grow from USD 16.34 Billion in 2023 to USD 27.62 Billion by 2033, at a Compound Annual...
IGM Biosciences Announces Refocusing of Sanofi Collaboration
April 17, 2024 08:30 ET
|
IGM Biosciences, Inc.
MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today...
Communiqué de presse : De nouveaux résultats de phase II à 48 semaines relatifs au frexalimab confortent le potentiel d'efficacité élevée et durable dans le traitement de la sclérose en plaques
April 17, 2024 01:00 ET
|
Sanofi - Aventis Groupe
De nouveaux résultats de phase II à 48 semaines relatifs au frexalimab confortent le potentiel d'efficacité élevée et durable dans le traitement de la sclérose en plaques Les données montrent que...